Chinese Biotech Firm Innovative Cellular Therapeutics Completes New Funding Round

Shanghai-based biotechnology company Innovative Cellular Therapeutics (ICT) has completed a new round of financing from LH Ventures, a venture capital form focusing on disruptive medical industry innovation.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!


Already have an account or paid subscription? Log in

Caishen.Co - Primary Data for China Secondary Investment and Stock Markets

LEAVE A REPLY